Qube Research & Technologies Ltd - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,096,833
-41.7%
39,061
-53.9%
0.01%
-57.1%
Q2 2022$1,880,000
+82.2%
84,801
+139.1%
0.01%
+55.6%
Q1 2022$1,032,000
-8.3%
35,466
+3.6%
0.01%0.0%
Q4 2021$1,126,000
+85.2%
34,241
+97.0%
0.01%0.0%
Q3 2020$608,000
+31.6%
17,385
+33.6%
0.01%
-52.6%
Q1 2020$462,00013,0090.02%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 354,650$18,314,0007.19%
Casdin Capital, LLC 2,165,000$111,801,0003.33%
Rock Springs Capital Management LP 2,543,600$131,352,0002.87%
HealthCor Management, L.P. 1,532,960$79,162,0002.80%
Bellevue Group AG 4,537,092$234,295,0002.48%
Woodline Partners LP 824,097$42,556,0000.94%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,081,347$55,841,0000.83%
Integral Health Asset Management, LLC 43,000$2,221,0000.64%
ArrowMark Colorado Holdings LLC 1,119,566$57,814,0000.43%
Virtus ETF Advisers LLC 18,328$946,0000.40%
View complete list of AGIOS PHARMACEUTICALS INC shareholders